Vinorelbine after paclitaxel in breast cancer: cross resistance and cumulative neurotoxicity?
Dittrich
C
C
Zifko
U
U
Fazeny
B
B
Fiegl
M
M
Grisold
W
W
Huber
H
H
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000009:adverse effects*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077235:Vinorelbine
D000970:Antineoplastic Agents; D014747:Vinblastine; D017239:Paclitaxel; D000077235:Vinorelbine